Enterome - Significant Progress with OncoMimics and EndoMimi

- First clinical proof of concept data with lead OncoMimics therapeutic cancer vaccine candidate EO2401 expected in H1 2022 - New Corporate Identity and Website Launched Today PARIS

Related Keywords

Paris , France General , France , Greece , Greek , Kostenloser Wertpapierhandel , Prnewswire Enterome , Sylvie Berrebi Mark , Head Of External Communications , Corporate Identity , Website Launched Today , External Communications , Investor Relations , Mark Swallow , Enterome , Significant , Progress , Ncomimics , Ndomimics , Pipelines , Transformational , Medicines , Dancer , Immune , Diseases ,